eHealthMe - Personalized health information & community eHealthMe - Personalized health information & community

Personalized health information & community


All drugs: A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
All conditions: A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Check symptoms   -   Check drugs   -   Compare drugs   -   Report a side effect
Join a support group   -   Ask a question   -   Write a review   -   Answered/ Unanswered   -   Reviews

Review: could Keppra cause Disseminated intravascular coagulation?

Summary: Disseminated intravascular coagulation is found among people who take Keppra, especially for people who are female, 30-39 old, have been taking the drug for < 1 month, also take medication Lamictal, and have Epilepsy.

We study 19,913 people who have side effects while taking Keppra from FDA and social media. Among them, 29 have Disseminated intravascular coagulation. Find out below who they are, when they have Disseminated intravascular coagulation and more.

You are not alone: join a support group for people who take Keppra and have Disseminated intravascular coagulation >>>

 

Keppra

Keppra has active ingredients of levetiracetam. It is often used in epilepsy. (latest outcomes from 21,249 Keppra users)

Disseminated intravascular coagulation

Disseminated intravascular coagulation (systemic activation of blood coagulation) has been reported by people with rheumatoid arthritis, preventive health care, high blood pressure, pain, infection. (latest reports from 14,200 Disseminated intravascular coagulation patients)

On Mar, 9, 2015: 19,909 people reported to have side effects when taking Keppra. Among them, 29 people (0.15%) have Disseminated Intravascular Coagulation.

Trend of Disseminated intravascular coagulation in Keppra reports

Time on Keppra when people have Disseminated intravascular coagulation * :

< 1 month1 - 6 months6 - 12 months1 - 2 years2 - 5 years5 - 10 years10+ years
Disseminated intravascular coagulation44.44%22.22%22.22%11.11%0.00%0.00%0.00%

Gender of people who have Disseminated intravascular coagulation when taking Keppra * :

FemaleMale
Disseminated intravascular coagulation52.94%47.06%

Age of people who have Disseminated intravascular coagulation when taking Keppra * :

0-12-910-1920-2930-3940-4950-5960+
Disseminated intravascular coagulation0.00%3.57%3.57%21.43%35.71%7.14%10.71%17.86%

Severity of Disseminated intravascular coagulation when taking Keppra ** :

n/a

How people recovered from Disseminated intravascular coagulation ** :

n/a

Top conditions involved for these people * :

  1. Epilepsy (14 people, 48.28%)
  2. Depression (7 people, 24.14%)
  3. Convulsion (4 people, 13.79%)
  4. Acute promyelocytic leukaemia (3 people, 10.34%)
  5. Pulmonary embolism (3 people, 10.34%)

Top co-used drugs for these people * :

  1. Lamictal (13 people, 44.83%)
  2. Protonix (7 people, 24.14%)
  3. Celexa (6 people, 20.69%)
  4. Ibuprofen (6 people, 20.69%)
  5. Tegretol (5 people, 17.24%)

* Approximation only. Some reports may have incomplete information.

** Reports from social media are used.

How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.

Do you have Disseminated Intravascular Coagulation while taking Keppra?

 

 

 

You are not alone! Join a support group on :
- support group for people who take Keppra and have Disseminated Intravascular Coagulation
- support group for people who take Keppra
- support group for people who have Disseminated Intravascular Coagulation

Drugs in real world that are associated with:

Could your condition cause:

Recent related drug studies (Check your drugs):

Recent Keppra related drug comparison:

NOTE: The study is based on active ingredients and brand name. Other drugs that have the same active ingredients (e.g. generic drugs) are NOT considered.

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

You may report adverse side effects to the FDA at http://www.fda.gov/medwatch/ or 1-800-FDA-1088 (1-800-332-1088).

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

   

About - Terms of service - Privacy policy - Press - Testimonials - Contact us - eHealth.me

 
© 2015 eHealthMe.com. All rights reserved. Use of this site constitutes acceptance of eHealthMe.com's terms of service and privacy policy.